Status: current, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4822421000168113 | relugolix (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4822431000168111 | relugolix | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| relugolix | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| relugolix + estradiol + norethisterone acetate | has intended active ingredient | True | relugolix | Inferred relationship | Some | 1610986496 |
| relugolix 40 mg + estradiol 1 mg + norethisterone acetate 500 microgram tablet | has Australian BoSS | True | relugolix | Inferred relationship | Some | 1161918954 |
| relugolix 40 mg + estradiol 1 mg + norethisterone acetate 500 microgram tablet | has intended active ingredient | True | relugolix | Inferred relationship | Some | 1161918954 |
| Ryeqo 40/1/0.5 tablet | has Australian BoSS | True | relugolix | Inferred relationship | Some | 33607532 |
| Ryeqo 40/1/0.5 tablet | has intended active ingredient | True | relugolix | Inferred relationship | Some | 33607532 |
This concept is not in any reference sets
FHIR